S1, Episode 10: A Path for Psychedelic Research - podcast episode cover

S1, Episode 10: A Path for Psychedelic Research

Dec 01, 202132 minSeason 1Ep. 10
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

Catherine Huff interviews Dr. Manish Jha and Dr. Madhukar Trivedi. There has been a renewed interest in researching psychedelic-assisted psychotherapy for the treatment of depression, anxiety, and other mental health disorders. But there is still much work to be done to understand this as a potential treatment. What is the mechanism by which psychedelics may work for depression? What are the risks associated with this kind of treatment? What has the research shown? What work needs to be done to have clear evidence of benefit and safety profiles?

 

Dr. Jha has substantial expertise in the conduct of clinical trials and extensive clinical experience in providing care to patients with treatment-refractory psychiatric illnesses. His research uses functional neuroimaging and affective neuroscience experiments to elucidate the neurocircuit mechanisms in order to develop the next generation of circuit-specific treatments for psychiatric disorders. Dr. Jha was involved with studies investigating ketamine for people with major depressive disorder. 

 

Follow us on podbean: utswcdrc.podbean.com 

Contact us at DecodingDepressionPodcast@UTSouthwestern.edu 

Learn more about the CDRC:

www.utsouthwestern.edu/labs/trivedi

www.utsouthwestern.edu/cdrc

For the best experience, listen in Metacast app for iOS or Android